#AVXL

Edelson Lechtzin LLP Investigates Anavex Life Sciences Corp. Due to Potential Violations Edelson Lechtzin LLP has announced a probe into Anavex Life Sciences Corp. for potential security law violations, particularly concerning misleading information about company performance.

2 months ago

Edelson Lechtzin LLP Investigates Anavex Life Sciences Corp. Due to Potential Violations #USA #Edelson_Lechtzin #Newtown #Anavex_Life_Sciences #AVXL

0 0 0 0

Pomerantz Law Firm Launches Investigation into Anavex Life Sciences Investors' Claims Pomerantz LLP is currently investigating claims for investors of Anavex Life Sciences Corp. related to potential securities fraud and market irregularities.

2 months ago

Pomerantz Law Firm Launches Investigation into Anavex Life Sciences Investors' Claims #United_States #New_York #Pomerantz_LLP #Anavex_Life_Sciences #AVXL

0 0 0 0

Investors Urged to Act: Pomerantz Law Firm Investigates Anavex Life Sciences Corp Claims Pomerantz Law Firm is probing potential securities fraud claims against Anavex Life Sciences Corp, following a significant stock drop. Investors are encouraged to reach out.

2 months ago

Investors Urged to Act: Pomerantz Law Firm Investigates Anavex Life Sciences Corp Claims #United_States #New_York #Pomerantz_LLP #Anavex_Life_Sciences #AVXL

0 0 0 0

Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion Anavex Life Sciences (Nasdaq: AVXL) requested that the European Medicines Agency (EMA) re-examine its opinion on blarcamesine for early Alzheimer’s disease on December 18, 2025.The company said the re-examination will be led by a different rapporteur and co-rapporteur and that Anavex asked the EMA to consult a Scientific Advisory Group to provide an independent recommendation. Anavex is a clinical-stage biopharmaceutical company developing treatments for Alzheimer’s and other CNS disorders.The release reiterates that blarcamesine is investigational, that efficacy and safety conclusions are not claimed, and that approval is not guaranteed.

2 months ago

#AVXL Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion

www.stocktitan.net/news/AVXL/anavex-life-sc...

0 0 0 0

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease Anavex Life Sciences (Nasdaq: AVXL) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a negative opinion on the marketing authorisation application for blarcamesine to treat early Alzheimer’s disease following an oral examination in November.The company intends to request a CHMP re-examination; EMA rules allow a re-examination by a different set of reviewers who will conduct a new, independent assessment. The release reiterates that investigational uses are not conclusions about efficacy or safety and that approval is not guaranteed.

3 months ago

#AVXL Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

www.stocktitan.net/news/AVXL/anavex-life-sc...

0 0 0 0

3 months ago

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#FRMI, #VRT, #RH, #MSTR, #AVXL

#OptionFlow #OptionsTrading #Trading

0 0 0 0

Pomerantz Law Firm Launches Inquiry for Anavex Life Sciences Corp. Investors Pomerantz LLP is investigating potential securities fraud claims against Anavex Life Sciences Corp. after recent troubling news. Investors are urged to respond.

3 months ago

Pomerantz Law Firm Launches Inquiry for Anavex Life Sciences Corp. Investors #USA #New_York #Pomerantz_Law_Firm #Anavex_Life_Sciences #AVXL

0 0 0 0

3 months ago

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#BE, #AVXL, #OPEN, #FUTU, #BITF

#OptionFlow #OptionsTrading #Trading

0 0 0 0

@mongodb.activitypub.awakari.com.ap.brid.gy

3 months ago

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #OMER 47% OTM
2. #RKLB 35% OTM
3. #PLTR 32% OTM
4. #BE 30% OTM
5. #AVXL 28% OTM

#OptionFlow #OptionsTrading #Trading

0 0 0 0

MongoDB

3 months ago

Top Stocks with Earnings This Week: Costco, Ulta and More - Salesforce (NYSE:CRM) Retail investors are prepping for a lighter week of corporate earnings featuring Costco, MongoDB, Ulta and more.

Top Stocks with Earnings This Week: Costco, MongoDB, Ulta and More Retail investors are prepping for a lighter week of corporate earnings featuring Costco, MongoDB, Ulta and more. read more

#AEO #AI #ATON #AVXL #CHPT #COST #CRDO #CRM #CRWD #CTRM #DG

Origin | Interest | Match

0 0 0 0

Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's

3 months ago

#AVXL Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update

www.stocktitan.net/news/AVXL/anavex-life-sc...

0 0 0 0

Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025 Anavex Life Sciences (Nasdaq: AVXL) will report fiscal 2025 fourth quarter and year‑end financial results on Tuesday, November 25, 2025. Management will host a conference call and live webcast on November 25 at 8:30 am ET to review results and recent corporate developments, followed by a Q&A session.Investors can access the live webcast at www.anavex.com or join by phone at 1 929 205 6099 (Meeting ID# 839 7768 4735, passcode 825109). A replay will be available on the company website for up to 30 days.

3 months ago

#AVXL Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025

www.stocktitan.net/news/AVXL/anavex-life-sc...

0 0 0 0

@stockmaster70.bsky.social

3 months ago

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! Weekly Top Unu

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

Weekly Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #GLXY 74% OTM
2. #HIMS 65% OTM
3. #HUT 54% OTM
4. #VFF 43% OTM
5. #AVXL 42% OTM

#OptionFlow #OptionsTrading #Trading

0 0 0 0

Stock Master

4 months ago

📢 Stocks Trending NOW: #TSLA #MSTR #CDTX #COIN #NVDA #IVVD #AVXL #WMT #ASBP #HOOD

0 0 0 0

Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease Anavex (Nasdaq: AVXL) said the CHMP delivered a negative trend vote on its MAA for oral blarcamesine for early Alzheimer’s disease after an oral explanation; a formal CHMP opinion is expected at the December meeting.The company intends to request re-examination of the CHMP opinion when adopted and will provide additional biomarker data. Separately, FDA CDER advised Anavex to request a meeting to discuss its Alzheimer’s clinical trial results.

4 months ago

#AVXL Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease

www.stocktitan.net/news/AVXL/anavex-life-sc...

0 0 0 0

4 months ago

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #QBTS 70% OTM
2. #HIMS 65% OTM
3. #AVXL 44% OTM
4. #HUT 40% OTM
5. #RGTI 38% OTM

#OptionFlow #OptionsTrading #Trading

0 0 0 0

4 months ago

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#AVXL, #HUT, #SMCI, #CIFR, #SMR

#OptionFlow #OptionsTrading #Trading

0 0 0 0

4 months ago

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #CRCL 56% OTM
2. #SMCI 33% OTM
3. #AVXL 26% OTM
4. #APLD 25% OTM
5. #FLNC 25% OTM

#OptionFlow #OptionsTrading #Trading

0 0 0 0

4 months ago

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#AVXL, #APLD, #FLNC, #OPEN, #HPK

#OptionFlow #OptionsTrading #Trading

0 0 0 0

4 months ago

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #AVXL 54% OTM
2. #CLSK 43% OTM
3. #VFF 43% OTM
4. #IFRX 41% OTM
5. #GLXY 40% OTM

#OptionFlow #OptionsTrading #Trading

0 0 0 0

4 months ago

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#AVXL, #CLSK, #VFF, #IFRX, #GLXY

#OptionFlow #OptionsTrading #Trading

0 0 0 0

4 months ago

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #IFRX 104% OTM
2. #BHVN 101% OTM
3. #AVXL 81% OTM
4. #CRCL 80% OTM
5. #BULL 73% OTM

#OptionFlow #OptionsTrading #Trading

0 0 0 0

Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’ Anavex (Nasdaq: AVXL) announced an oral presentation delivered by Prof. Dr. Timo Grimmer, MD, member of the company's Scientific Advisory Board and National Coordinating Investigator for the blarcamesine Phase IIb/III ANAVEX®2-73-AD-004 study, at the 35th Alzheimer Europe Conference on October 10, 2025.The presentation, titled “Advancing Alzheimer’s Disease Care: Convenience for Both Patients and Families with Oral Blarcamesine,” is available on Anavex’s investors website.This release discusses investigational uses of an agent in development and does not draw conclusions about efficacy or safety; there is no guarantee the investigational product will complete clinical development or obtain health authority approval.

5 months ago

#AVXL Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’

www.stocktitan.net/news/AVXL/anavex-life-sc...

0 0 0 0

Novel Schizophrenia Drug ANAVEX3-71 Shows Promise: Safe Profile and Reduced Brain Inflammation Markers Anavex's ANAVEX3-71 achieves primary safety endpoint in Phase 2 schizophrenia study, demonstrating positive biomarker trends and reduced GFAP inflammation markers. No serious adverse events reported.

5 months ago

#AVXL Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

www.stocktitan.net/news/AVXL/anavex-life-sc...

0 0 0 0

70% Success Rate: Anavex's Once-Daily Oral Alzheimer's Drug Shows Breakthrough Results in Late-Stage Trial Oral Blarcamesine demonstrates significant cognitive improvements in early Alzheimer's patients. Precision medicine approach benefits 70% of participants with superior efficacy vs approved therapies.

5 months ago

#AVXL Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial

www.stocktitan.net/news/AVXL/anavex-life-sc...

1 0 0 0

Small Cap Strategist

@smcapstrategist.bsky.social

6 months ago

Most Searched, Tuesday September 9, 2025 – Crystal Equity Research

Most searched small-cap stocks, Tue Sept 9th - #ONDS #TRML #CIFR #IBRX #PL #OCTO #RZLV #HIVE #PTNM #VERI #CWD #UPXI #RR #STSS #SINT #QMMM #FTF #ESPR #CVI #AVXL - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0